Research Areas
Molecular Biology ● Molecular Genetics ● RNA Helicase ● Translation ● Splicing ● Proteome Homeostasis ● Integrated Stress Response ● Branched-Chain Amino Acid ● Integumentary System ● Shh & Wnt Pathways
Cells must keep both the quantity and the quality of their transcriptome and proteome in balance, especially under stress. We study the mechanisms that maintain this balance, and how their failure leads to the deterioration of tissues and organs during aging.
Our work focuses on molecular mechanisms, but we try to keep a broader view: we revisit what we find in the light of evolution, asking why these mechanisms arose and how they have been shaped across species.
"Nothing in biology makes sense except in the light of evolution."
— Theodosius Dobzhansky (1973)
Every protein in a cell must be made in the right amount, at the right time, and kept in good condition. Translation, the step at which mRNA is read to make protein, is one of the main points where cells adjust their proteome, especially under stress. The RNA helicase DDX3 unwinds structured mRNAs and helps ribosomes initiate translation on many transcripts, so changes in DDX3 activity can reshape which proteins a cell makes. We study the mechanisms by which DDX3 regulates protein synthesis, and how this quantitative control of the proteome interacts with protein quality control during aging and cellular stress. We are particularly interested in how cells keep these two layers in balance, and what happens to tissues when that balance is lost.
The branched-chain amino acids (BCAAs) leucine, isoleucine and valine are essential amino acids. Beyond serving as building blocks of proteins, they act as signals of nutrient status that influence cell growth and metabolism, and their levels in cells and tissues change with diet, disease and age. Our earlier work showed that microRNA-mediated suppression of BCAA catabolism promotes ferroptosis in chronic kidney disease. We now study how BCAA metabolism affects gene expression and proteome homeostasis in aging cells and tissues, and how changes in BCAA levels influence cellular senescence. This work links nutrient metabolism to the control of protein synthesis and quality at the center of our DDX3 research.
The two areas above are our current main focus, but our research directions are not fixed; they evolve as new questions and findings emerge.
▪ Shh and Wnt signaling — how the activity of the Ci/Gli family of transcription factors is regulated, and likewise how β-catenin and TCF control Wnt target gene expression, building on our earlier work on Hedgehog signal transduction.
▪ DDX3 in cancer — DDX3X is frequently mutated in medulloblastoma, particularly in the Shh and Wnt subtypes, and is altered in several other cancers. We explore how these mutations change DDX3 function and contribute to uncontrolled cell proliferation.
▪ DDX3X syndrome — germline DDX3X variants, most of which arise de novo, cause DDX3X syndrome (DDX3X-related neurodevelopmental disorder), which accounts for 1–3% of unexplained intellectual disability in females. Unlike in cancer, the question here is how loss of DDX3 function disturbs brain development. We investigate the pathogenesis of DDX3X syndrome and build disease models to study it.
▪ DDX3 beyond translation — how DDX3 interacts with the ribosome and with splicing components, how DDX3 regulates splicing, and how it shapes cellular responses to transposons.
▪ Integrated stress response and protein folding — how cells sense and resolve stress through the integrated stress response (ISR), and how protein folding is regulated to protect the quality of the proteome. We build fluorescent reporters for these pathways and use them in screens to identify new regulators.
Human cell lines and hiPSC-derived 3D organoids, including a skin model of UV-induced aging and barrier damage. The skin model is one of several systems we use to study how proteome failure affects tissues and organs.
"What is true for E. coli is also true for the elephant."
— Jacques Monod
Recombinant DNA technology, genome-wide CRISPR screening, RNA-seq, high-content imaging, APEX2 proximity labeling, ubiquitinome profiling, and LC-MS/MS amino acid analysis, along with other molecular, cellular, and omics approaches.
We collaborate with research groups in the United States and Korea. Selected collaborators include:
▪ Eun-Young (Erin) Ahn, Ph.D. — University of Alabama at Birmingham, USA
▪ Steve Ssang-Taek Lim, Ph.D. — University of Alabama at Birmingham, USA
▪ Byoung-San Moon, Ph.D. — Yeungnam University, Korea
▪ Joon Tae Park, Ph.D. — Incheon National University, Korea
▪ Hyun Joon Kim, Ph.D. — Gyeongsang National University, Korea
Our research has been supported by:
▪ National Research Foundation of Korea (NRF)
▪ Korea Health Industry Development Institute (KHIDI)
▪ Korea Technology and Information Promotion Agency for SMEs (TIPA)
▪ Korea Foundation for Science and Creativity (KOSAC)
▪ Catholic Kwandong University (internal research grants)
▪ Catholic Kwandong University International St. Mary's Hospital